Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFeedback Regulatory News (FDBK)

Share Price Information for Feedback (FDBK)

Share Price is delayed by 15 minutes
Get Live Data
7.65    0.00 (0.00%)
Bid:
7.40
Ask:
7.90
Spread: 0.50 (6.757%)
Market Cap: £3.35m
FDBK Live PriceLast checked at - London Stock Exchange

Intraday Feedback Share Chart

Director Appointment

29 Nov 2021 13:36

RNS Number : 9144T
Feedback PLC
29 November 2021
 

Feedback plc

 

Appointment of Anesh Patel as Chief Financial Officer and Company Secretary 

 

Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the specialist clinical communication company, is pleased to announce that further to previous announcements, Anesh Patel has been appointed to the board of directors as Chief Financial Officer and Company Secretary with immediate effect.

 

Anesh Patel was appointed as Chief Financial Officer of Feedback's wholly owned subsidiary, Feedback Medical Limited, in May 2021 as part of a succession planning programme following Lindsay Melvin's (Chief Financial Officer and Company Secretary of Feedback) decision to retire from the board of Feedback during H2 2021. Anesh has worked alongside Lindsay over the past months to ensure a smooth and orderly transition.

 

Anesh joined Feedback Medical Limited from hVIVO Limited, a subsidiary of AIM-listed Open Orphan plc and a rapidly growing, industry-leading, clinical services provider to pharma, biotech and government organisations where most recently he was finance & corporate projects director. Prior to hVIVO, he spent seven years in investment banking where he specialised in corporate finance advisory services, at leading banks including Société Générale and Standard Bank. Anesh started his professional career with Ernst & Young in 2004 where he qualified as a chartered accountant, initially working within the audit & assurance division before transferring to the transaction support team for private equity clients. He graduated from University College London (UCL) and holds an M.Sci. (Hons) degree in Mathematics with Economics.

 

Rory Shaw, Chairman of Feedback, commented: "We welcome Anesh to the Board of Feedback. He joined the team earlier this year and has already proven the value he brings through his contribution to the successful £11.2 million fundraise recently announced. His broad financial and commercial experience provides a good balance to the medical and technical expertise we have across the Board, creating a strong team to take the Company forward. I would also like to take this opportunity to thank Lindsay for his work guiding the Company through its formative years, and for enabling a smooth handover to ensure Feedback continues on this trajectory of growth. We believe that Feedback is set for a bright and exciting future ahead."

 

Aneshkumar (Anesh) Ishwarbhai Patel (aged 40) does not currently hold any directorships and has no previous directorships (within 5 years). Anesh Patel has confirmed that there is no further information to be disclosed pursuant to paragraph (g) of Schedule 2 of the AIM Rules.

 

Enquiries:

 

Feedback plc

Tom Oakley, CEO

Anesh Patel, CFO

+44 (0)1954 718072

IR@fbk.com

Panmure Gordon (UK) Limited (NOMAD and Broker)

Emma Earl/Freddy Crossley (Corporate Finance)

Rupert Dearden (Corporate Broking)

+44 (0)20 7886 2500

Walbrook PR Ltd

Tel: 020 7933 8780 or feedbackplc@walbrookpr.com

Paul McManus/Nick Rome/Nicholas Johnson

07980 541 893 or 07748 325 236 or 07884 664 686

 

Notes to Editors

 

Feedback plc (AIM: FDBK) is a pioneer of regulated clinical communication products. Its core product, Bleepa, is a revolutionary medical imaging communications app, providing an easy-to-use, high quality tool to enable remote and secure communications between front-line clinicians and teams. Importantly, it is the only CE marked medical imaging communications platform on the NHSx clinical communications tools framework. Bleepa has unparalleled functionality for everyday practice and can be accessed from any internet-connected device, enabling control of patient cases when on the go.

 

Its highly scalable Software as a Service ("SaaS") based revenue model will provide increasing levels of visibility as the Company grows its customer base. With a growing distribution base and technology in place, the focus is on leveraging key relationships in order to drive sales both in the UK and internationally to all forms of care providers. As a fully certified medical device, Bleepa aims to disrupt the medical imaging communications market and, importantly, increase the accuracy and speed of clinical review.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADKCBBNBDDFDB
Date   Source Headline
27th Feb 20157:00 amRNSAttendance at European Congress of Radiology
13th Feb 20157:00 amRNSHalf Yearly Report
20th Nov 201410:59 amRNSResult of AGM
11th Nov 20141:39 pmRNSTexRAD technology assists in medical trials
30th Oct 20149:16 amRNSPosting of Report & Accounts and Notice of AGM
28th Oct 20147:00 amRNSFinal Results
15th Aug 20142:16 pmRNSDirector/PDMR Shareholding
3rd Jul 201412:17 pmRNSDirector/PDMR Shareholding
30th Jun 20148:00 amRNSDirector/PDMR Shareholding
19th Jun 20142:28 pmRNSChange of Registered Office
16th May 201411:18 amRNSResult of EGM
30th Apr 20149:41 amRNSSchedule 1 - Feedback Plc
30th Apr 20147:01 amRNSAcquisitions Subscription and Admission to Trading
6th Mar 20147:00 amRNSChange of Adviser
19th Feb 20147:00 amRNSHalf Yearly Report
13th Jan 20148:00 amRNSDirectorate Change
20th Dec 20137:00 amRNSHolding(s) in Company
12th Dec 20134:08 pmRNSHolding(s) in Company
12th Dec 20134:07 pmRNSHolding(s) in Company
29th Nov 201312:33 pmRNSResult of AGM
20th Nov 20137:00 amRNSHolding(s) in Company
19th Nov 20137:00 amRNSHolding(s) in Company
12th Nov 20137:01 amRNSHolding(s) in Company
6th Nov 20137:00 amRNSFinal Results
30th Jul 201312:18 pmRNSDisposal of freehold property
29th Jul 201310:46 amRNSResult of General Meeting
11th Jul 20137:00 amRNSDisposal of Freehold Property
3rd Jun 20137:00 amRNSDisposal and Director Change
30th May 201310:50 amRNSResult of General Meeting
14th May 20137:00 amRNSDisposal
13th May 20135:37 pmRNSHolding(s) in Company
19th Mar 20137:00 amRNSAdviser Change of Name
25th Feb 20137:00 amRNSFinal Results
30th Nov 201212:48 pmRNSResult of AGM
12th Nov 20127:00 amRNSDirectorate Change
7th Nov 20127:00 amRNSFinal Results
1st Nov 20127:00 amRNSChange of Registered Office
16th Oct 20127:00 amRNSDirectorate Change
23rd May 20123:58 pmRNSDisposal of Feedback Instruments Limited
11th Apr 20126:27 pmRNSForm 8.3 - Feedback Plc
7th Feb 20127:00 amRNSHalf Yearly Report
24th Nov 20117:00 amRNSDirectors' Shareholding
31st Oct 20116:02 pmRNSTotal Voting Rights
19th Oct 20117:00 amRNSDirector's Shareholding
17th Oct 20117:00 amRNSDirectorate Change
14th Oct 20117:00 amRNSGrant of Options
28th Sep 20117:00 amRNSIssue of Equity
2nd Sep 201111:57 amRNSResult of AGM
29th Jul 20117:00 amRNSFinal Results
3rd May 20117:00 amRNSChange of Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.